The meeting theme was about Pricing and Reimbursement of Pharmaceuticals. It was a great opportunity for key stakeholders, reimbursement bodies and governmental sector to share their challenges been encountered with the current innovative therapies and new technologies from pricing and reimbursement perspective. Active participation and sharing proposals was wonderful, as usual, from all stakeholders.
